Nan G Ring

Anti-SIRPα antibody immunotherapy enhances neutrophil and macrophage antitumor activity

I. Weissman, R. Flavell, B. George, 2017, Proceedings of the National Academy of Sciences.

Engagement of MHC class I by the inhibitory receptor LILRB1 suppresses macrophages and is a target of cancer immunotherapy

I. Weissman, A. Barkal, B. George, 2017, Nature Immunology.

Evolutionarily conserved resistance to phagocytosis observed in melanoma cells is insensitive to upregulation of pro-phagocytic signals and to CD47 blockade

I. Weissman, J. Modiano, D. Ito, 2019, Melanoma research.